Table 1.
IEM General classification |
IEM associated with endocrine manifestations and most important mechanism | ENDOCRINE MANIFESTATIONS | |||||
---|---|---|---|---|---|---|---|
Diabetes | Dysthyroidism | Hypopara- thyroidism |
Adrenal failure | Hypogonadism | Hypopituitarism | ||
INTOXICATION Metal intoxication Haemochromatosis Aceruleoplasminemia Wilson's Sugar intolerances Galactosaemia Most organic acidurias |
Haemochromatosis Iron storage |
Diabetes 10% |
< 1% | < 1% | < 1% |
Hypogonadotropic 5-10% |
< 1% except for acquired iron overload and hypogonadism |
Aceruloplasminemia Iron storage |
Diabetes | rare | |||||
Wilson's disease Copper storage |
Hypoparathyroidism rare |
||||||
Galactosaemia Galactose metabolites |
Hypergonadotropic in female |
Short stature | |||||
Organic aciduria Organic acids |
Possible ketoacidosis pancreatitis |
||||||
ENERGY DEFECT Mitochondrial disorders: Respiratory chain disorders Fatty acid oxidation defects |
Respiratory chain defect Deficient energy production |
Diabetes | All types of thyroid dysfunction | Hypoparathyroidism rare |
Subclinical adrenal failure |
Hypogonadotropic |
Hypopituitarism Short stature 30 to 50% |
LCHAD Deficient energy production |
Hypo- parathyroidism |
||||||
Cytoplasmic energy defects Disorders of glycogen metabolism |
Glycogenosis Glycogen storage (type I, III) |
Diabetes |
Thyroid dysfunction (type Ib) |
Mixed or undetemined PCOS (type I) |
|||
COMPLEX MOLECULES Peroxisomal disorders |
X-linked adreno-leukodystrophy Perrault syndrome VLCFA accumulation |
Adrenal failure |
Mixed or undetemined (mainly hypergonadotropic) |
||||
Lysosomal disorders |
Fabry disease Globoside storage in lysosomes |
Subclinical hypothyroidism |
Subclinical adrenal failure | Infertility | |||
Cystinosis Cystine in lysosomes |
Diabetes |
Hypothyroidism 75% |
Hypergonadotropic |
Short stature 30 to 50% |
|||
Disorders of intracellular trafficking and processing such as Congenital disorders of glycosylation Inborn errors of cholesterol synthesis. |
CDG I Abnormal glycosylated proteins |
Congenital hypothyroidism |
Mixed or undetermined mainly hypergonadotropic |
||||
Multisystemic triglyceride storage disease Triglyceride storage in endoplasmic reticulum |
Thyroid dystrophy | ||||||
Type 1 hyperoxaluria Oxalate |
Hypothyroidism | Advanced bone age |
|||||
Type B Niemann-Pick disease Sphingolipid storage in lysosomes |
Partial rare |
Short stature | |||||
TRANSPORTER DEFECT |
Rogers syndrome: Thiamine-sensitive megaloblastic anaemia Defective ATP production in ß cells |
Diabetes | |||||
MCT8 deficiency Defective T3 transport in neurons |
High blood T3 | ||||||
Alström syndrome | Diabetes | Hypothyroidism | Hyper- and hypogonadotropic (men) PCOS in women |
Rare hypopituitarism Initial advanced bone age |
|||
Selenoprotein deficiency disorder | Low T3-High T4 | Oligospermia | Short stature |
CDG: congenital disorders of glycosylation; IEM: inborn errors of metabolism; LCHAD: long-chain 3-hydroxyacyl-CoA dehydrogenase deficiency; MCT8: Monocarboxylate transporter; PCOS: polycystic ovary syndrome; T3: triiodothyronine; T4: thyroxine; VLCFA: Very long chain fatty acids.